INTRODUCTION
Medicare SELECT is an individually purchased Medicare supplemental insurance policy that requires beneficiaries to use the insurer's provider network (to the extent that a network exists) to receive supplemental benefits. Medicare benefits are unaffected by whether the beneficiary uses the supplemental insurer's network (and receives supplemental benefits) or goes outside the network (and forfeits supplemental benefits). In creating SELECT Congress expected that it would direct beneficiaries to networks of efficient providers established by the supplemental insurers. This would in turn reduce fee-forservice (FFS) Medicare claims and enable SELECT insurers to offer beneficiaries lower premiums. In this article we present A. James Lee and Rezaul K. Khandker are with Health Economics Research, Inc.; Steven A. Garfinkel is with Research Triangle Institute; and Edward C Norton is with the University of North Carolina at Chapel Hill.
an evaluation of the impact of SELECT (during the January 1, 1992-December 31, 1994 demonstration period) on Medicare program costs and beneficiary utilization in 11 States. The impact of SELECT on supplemental insurance premiums and beneficiary access and satisfaction is addressed elsewhere .
Medicare SELECT is one of several attempts to introduce managed care incentives into the FFS Medicare system. Although enrollment in Medicare health maintenance organizations (HMOs) has grown rapidly in recent years, it still represents only 13 percent of the Medicare population and may continue to represent a minority of the Medicare population for the foreseeable future. Thus, the growth of expenditures in the FFS Medicare system will continue to be a key factor in the financial health of the Medicare program. This evaluation not only bears on the extent to which SELECT has achieved its cost-containment objectives but also contributes to the growing body of information about the prospects for managed care techniques as a way to reduce the long-term growth in Medicare program expenditures.
BACKGROUND
The Omnibus Budget Reconciliation Act (OBRA) of 1990 made two important changes in the regulation of Medicare supplemental insurance. First, the law imposed mandatory standards for individually purchased medigap insurance. These standards, which took effect in 1992, limited medigap policies to 10 standard plans, labeled A through J, and guaranteed issue for Medicare beneficiaries within 6 months of eligibility for Medicare Part B. Second, OBRA 1990 allowed medigap insurers in 15 States to market network-based medigap products, called Medicare SELECT policies, on a 3-year demonstration basis.
SELECT products offer a managed care alternative to traditional medigap insurance. In most instances the SELECT benefits are the same as standard medigap plans.
1 Like an HMO, however, SELECT plans pay supplemental benefits only when contracting network providers are used. Because Medicare SELECT plans are supplemental policies, they have no effect on Medicare program payments. The FFS Medicare program makes its payments whether or not services are delivered in or out of the SELECT network. Thus, from the beneficiary's perspective, SELECT plans function like a preferred provider organization (PPO) in that, when out-of-network providers are used, most of the cost (i.e., the Medicare program's obligation) is still covered, but some of the cost (i.e., the supplemental insurer's obligation) is not.
The 15 States initially designated as SELECT States are Alabama, Arizona, California, Florida, Indiana, Kentucky, Michigan, Minnesota, Missouri, North Dakota, Ohio, Oregon, Texas, Washington, and Wisconsin. Oregon and Michigan, however, quickly withdrew because of a lack of insurer interest and, in mid-1993, Illinois and Massachusetts were selected as replacements.
Although the Health Care Financing Administration (HCFA) was responsible for supervising the SELECT program, actual implementation was the responsibil-1 Because they already had standardized medigap plans, three SELECT States (Massachusetts, Minnesota, and Wisconsin) were not required to implement the OBRA 1990 standardization. In these States SELECT insurers were permitted to market plans that corresponded to their existing State-specific medigap plans.
ity of the department of insurance in each State. Within the guidelines of the National Association of Insurance Commissioners' (NAIC) model legislation, each State implemented SELECT according to its own insurance regulations, procedures, and standards. Moreover, the Statespecific implementations were substantially shaped by the insurers themselves, who were required to seek approval from the State departments of insurance before marketing a SELECT product. In our case studies of the State implementations, we found considerable variation across States in how SELECT was implemented (Lubalin et al., 1994) .
The original 3-year demonstration, which had been scheduled to end December 31, 1994 , was extended to June 30, 1995 , by the Social Security Amendments of 1994 . In late June 1995, Congress expanded the authority to offer Medicare SELECT plans to all States (Public Law 104-18). SELECT was extended until June 30, 1998, at which time it will become permanent, unless the Secretary of Health and Human Services finds that it (1) has not resulted in savings of premium costs to beneficiaries, compared with non-SELECT medigap policies; (2) has resulted in significant additional expenditures for the Medicare program; or (3) has resulted in diminished access and quality of care.
EVALUATION QUESTIONS
In authorizing this demonstration, legislators had anticipated that Medicare SELECT products would (1) reduce Medicare program expenditures by directing beneficiaries to efficient provider networks established by medigap insurers; (2) reduce beneficiary expenditures for medigap coverage, because insurers would pass the savings from provider efficiencies on to beneficiaries through lower premiums; and (3) achieve these savings without compromising quality of care. Our evaluation was designed to answer these questions, in addition to providing basic descriptive information about how SELECT was implemented by States and insurers.
In this article we address the question of how SELECT has affected Medicare program expenditures and utilization. However, it is useful to first summarize the prevalence of SELECT offerings and enrollment and their impact on beneficiaries to provide the context to understand SELECT's impact on Medicare program costs.
SELECT Implementation
A summary of SELECT participation by States, insurers, and beneficiaries is provided in Table 1 percent. Throughout the original 3-year demonstration and the ensuing 18 months of SELECT activity, BCBS affiliates consistently accounted for three-fourths of all SELECT enrollment, despite the fact that a larger number of commercial insurance companies and HMOs were participating.
The most interesting aspect of SELECT implementation, and the one with the greatest implications for program impact, is the decision made by many insurers to either use hospital-only provider networks or include almost all physicians and hospitals in the State. Of the 121 companies offering SELECT in 1996, 86 (71 percent) had hospital-only networks. This includes 77 of the 79 (97 percent) commercial insurance companies offering SELECT plans. Insurers adopted this model because (1) they believed that the only significant savings to be found in the SELECT program would come from discounts or waivers of the Medicare Part A deductible by hospitals; (2) the transaction cost of establishing physician networks is high; and (3) HCFA has approved a "safe harbor" for discounts on the Part A deductible but not for Part B coinsurance (Lubalin et al., 1994) .
Effects on Beneficiaries
We considered the effects of SELECT on Medicare beneficiaries in terms of the medigap premiums they face and their experiences with SELECT coverage. Because premiums vary according to the insurer's claims experience and actuarial judgment, benefit package (e.g., A-J), and ratesetting method (e.g., attained age, issue age, or community rating), it was important to make comparisons within company and plan type for those companies that offered the same plans as SELECT and standard medigap policies. We computed ratios of 1996 SELECT to standard medigap premiums for non-smok- --
* Newly approved plans (since November 1995).
1
As of December 31, 1995.
2 Plans A through J are standard plans developed by the National Association of Insurance Commissioners.
3
Codes for comments are: 1 = plan is a service corporation; 2 = plan is a health maintenance organization (HMO); 3 = organization affiliated with Olympic Health Management Systems, Inc.; 4 = State has waiver from standardization, so plans do not conform to A-J; 5 = SELECT network does not include physicians.
4
Codes for type of premium are: C = community rated; A = attained age; I = issue age; NA= not available. ing women of ages 65 years and 75 years and found that SELECT premiums were less expensive on average than the premiums for the standard medigap versions for the same policies offered by the same companies. The differences ranged from 15-29 percent at age 65 and 11-29 percent at age 75, depending on type of plan. Such differences could be attributable to the use of efficient physicians by insurers who use selective physician networks but almost certainly derives substantially from the discounts or waivers of the Part A deductible by network hospitals. However, these differences could also reflect favorable selection in Medicare SELECT, an issue addressed later in our analysis of Medicare program costs.
It is important to note, however, that there are often policies available that have lower premiums than the standard policy offered by the SELECT insurer. Thus, new Medicare beneficiaries, who are guaranteed issue for their first 6 months of Part B eligibility, can often obtain a policy that is less expensive than the SELECT policy. Clearly SELECT is not producing the least expensive policies in the market, and price is not the sole factor in the choice of medigap policy.
From our survey of Medicare beneficiaries, we compared those who had purchased SELECT policies with those who had standard medigap policies. We found that persons of races other than white and persons in low socioeconomic groups were more likely to purchase a SELECT product than were white persons and wealthier, better educated beneficiaries. This is consistent with the finding that SELECT premiums are comparatively inexpensive for beneficiaries 65 years of age. We also found no difference in health status between the two groups, which suggests that selection bias is less likely as an explanation for cost differences.
Finally, we found no difference in satisfaction with medigap insurance between purchasers of SELECT and standard unrestricted products. If beneficiaries who purchase SELECT, presumably to obtain lower premiums, were less satisfied than the comparison group, then one might conclude that buying SELECT is a "bad" bargain. However, the evidence suggests that the two groups are equally satisfied and that, holding all else constant, SELECT is a reasonable choice for beneficiaries who are willing to accept some restriction in choice of provider to obtain a lower premium.
ANALYTIC APPROACH
In evaluating SELECT effects on Medicare program cost and utilization, we use a "four-way" quasi-experimental design, comparing the before-and-after enrollment experiences of Medicare beneficiaries newly enrolled in SELECT plans with the before-and-after enrollment experiences of a matched sample of Medicare beneficiaries newly enrolled in traditional post-OBRA medigap plans
The study population included beneficiaries who were enrolled in either SELECT or post-OBRA standard medigap plans in February 1994. Twenty-four of 26 SELECT insurers supplied the Medicare identification numbers of beneficiaries who had purchased their SELECT and standard medigap plans. In addition, several BCBS affiliates that did not offer SELECT plans and the Prudential/American Association of Retired Persons medigap plan submitted identification numbers of standard plan purchasers to expand the pool of potential comparison group members. All identification numbers that could be matched to the Medicare eligibility file were eligible for the study. We were able to match 81 percent of the SELECT identification numbers in the 12 States with SELECT enrollment in February 1994.
All eligible SELECT beneficiaries were included in the analysis. The comparison group was constructed by selecting a stratified random sample of the eligible standard plan purchasers matched to the age, sex, and ZIP Code distribution of the eligible SELECT population.
We then evaluated the effects of SELECT on 14 different measures of cost and utilization. Although we report results for all measures, we focus on our most comprehensive cost measure, total allowable Medicare expense (including deductibles and copayments). Thus, the greatest attention is given to answering the principal policy question, namely, does SELECT reduce total Medicare costs?
We estimated the cost models as log-linear relationships, and we estimated the utilization models as linear relationships. We found that this approach gave the most robust estimates across different model types and different dependent variables. All models were estimated separately for each State.
Fixed-Effects Model
Preliminary analyses using a simple cross-section/time-series design indicated potential selection bias. Specification tests showed significant differences in the Medicare costs incurred prior to enrollment in the current medigap plan, even after controlling for observable characteristics (Heckman and Hotz, 1989) . In an effort to mitigate selection bias, we used the fixed-effects procedure in estimating SELECT effects. Fixed-effects is the standard econometric procedure for avoiding or reducing selection bias. It controls completely for time-invariant differences among individuals.
In estimating the fixed-effects models, we estimated a unique intercept for each individual beneficiary. Although this procedure controls for all measured and unmeasured person-specific characteristics, it also means that all time-invariant variables (e.g., sex, race, location, and reason for entitlement) are excluded from the estimation and cannot be included as explicit control variables. Indeed, this is the major limitation of fixed-effects estimation-that one cannot ascertain the role or importance of time-invariant covariates. For this reason we also estimated cross-section/time-series models without using fixed effects. We nevertheless believe that the fixed-effects estimation provides the more robust and reliable estimates of SELECT effects. It provides the strongest control for self-selection or specification bias as an alternative explanation for observed cost differences.
The fixed-effects models include only the variables that vary over time. In particular, the fixed-effects models include three key variables: SELECT (indicating SELECT program effects), MEDIGAP (indicating traditional medigap effects), and QUARTER. SELECT is the treatment variable, with a range from zero to one. For SELECT enrollees, it is set equal to zero for quarters prior to SELECT enrollment. It is set equal to one for quarters after SELECT enrollment For the quarter in which SELECT enrollment occurred, SELECT is defined proportionately (e.g., set equal to 0.50 if enrollment occurred midway through a quarter). For non-SELECT enrollees this SELECT variable is always zero. This variable is our indicator of the SELECT program effect.
To distinguish pre-enrollment quarters from post-enrollment quarters, we used another dummy variable designated MEDI-GAP. For all beneficiaries this variable is set equal to zero for quarters prior to enrollment in a post-OBRA medigap product. It is set equal to one for quarters after such enrollment. For SELECT enrollees only, the SELECT and MEDIGAP variables have the same values. Thus, the MEDIGAP variable controls for or distinguishes the effect of enrollment in any post-OBRA medigap product, traditional or SELECT, and the SELECT variable distinguishes the incremental or differential effect of enrollment in a SELECT product. Thus, for SELECT enrollees, the effects are additive.
We also included a variable, QUARTER, to account for time-trend effects. QUAR-TER takes a value ranging from 1 through 16, depending on which of the 16 quarters in our data set is represented by the observation. Finally, three dummy variables are used to control for seasonal variation in health care use, with winter being the omitted category.
Cross-Section/Time-Series Model
This model includes not only the variables included in the fixed-effects model but also a number of time-invariant beneficiary characteristics. A dummy variable (EVER) identifies those ever enrolled in a SELECT product. This variable distinguishes the SELECT group from the comparison group and controls for prior-use differences between the SELECT and non-SELECT beneficiaries. In essence, EVER distinguishes the experimental group from the comparison group, MEDIGAP distinguishes pre-enrollment quarters from postenrollment quarters, and SELECT represents the interaction of the two. Of course we could not include EVER in the fixedeffects model because it does not vary over time.
A number of beneficiary demographic characteristics were also included as independent variables in the crosssection/time-series estimation to control explicitly for health status and other individual differences between the SELECT and comparison beneficiaries.
3 Finally, to control for geographic variation in provider availability and payment rates, we included dummy variables identifying county of beneficiary residence; and to control for insurer differences in risk selection, we included dummy variables distinguishing the various SELECT and non-SELECT insurers. Whereas the cross-section/time-series model specification is reasonably comprehensive, it is nevertheless important to acknowledge that this basic cross-section/time-series model and all other models estimated were incompletely specified. In particular, we had no information on the beneficiaries' prior supplemental insurance status. We did not know whether a given beneficiary had another medigap product during the time interval prior to reported enrollment in a post-OBRA traditional or SELECT product. As a practical necessity, our analysis must assume that the traditional and SELECT enrollee populations had the same distribution of supplemental benefits prior to post-OBRA enrollment. To the extent that this assumption is incorrect, our estimates of the medigap and SELECT impacts could reflect bias.
If, for example, SELECT (because of price advantage or market positioning) were relatively more attractive to Medicare beneficiaries without a prior supplemental plan, our estimates of the SELECT effects could have a positive bias. Health services research has consistently shown that beneficiaries with supplemental insurance have higher Medicare costs than those without (Christenson, Long, and Rodgers, 1987;  3 The beneficiary variables are as follows: six continuous variables (AGE65, AGE70, AGE75, AGE80, AGE85, and AGEGT85), specifying age in a piecewise linear fashion, a dummy variable (FEMALE) identifying those who are female, a dummy variable (BLACK) identifying those who are black, and a dummy variable (OTHER) identifying those who are of races other than black or white. To control for the beneficiary's Medicare eligibility status, which is associated with health status by definition: a dummy variable (DISABLED), identifying those who are disabled, a dummy variable (RENAL), identifying those with renal disease, a dummy variable (AGED_DIS), identifying those who are aged and disabled, and a dummy variable (AGED_REN), identifying those who are both aged and have renal disease. Link, Long, and Settle, 1980; McCall et al, 1991; and Khandker and McCormack, 1996) . Indeed, our own results provide additional, strong support for that proposition. If so, a cost-increasing result would be obtained if those enrolling in SELECT had been less likely to have a supplemental plan prior to post-OBRA enrollment.
Unfortunately, no comparative information was available on the prior insurance status of the SELECT and comparison beneficiaries. However, we believe that the potential for such selection bias is much diminished in those States with very large SELECT enrollment (e.g., Alabama, California, and Minnesota). Their SELECT populations are much more likely to be representative of the larger Medicare beneficiary universe in those States. Furthermore, inasmuch as our findings for these three States mirror the pattern of results for all States in which SELECT is evaluated, we do not believe that the differences seen are wholly or even substantially attributable to such selection bias.
Other Models
In addition to the fixed-effects and cross-section/time-series models, we estimated other models to check the robustness of our results. We estimated an expanded fixed-effects model that also included the time-invariant covariates (e.g., gender and race). We estimated a prior-use model in which the dependent variable in the last year of our data was modeled as a function of the baseline value of the dependent variable in the first year of our data, in addition to other factors. We also estimated a first-difference model wherein the dependent variable was constructed as the difference between experience in the first and last years of our data. These models, with the possible exception of the first-difference model, yielded results that are broadly consistent with the fixed-effects model and indicate similar appraisal of the SELECT program. However, none of these models is as theoretically appealing or empirically robust as the fixed-effects model. The fixed-effects model reported herein clearly provides the best estimate of SELECT program effects. The fixed-effect results are more stable than the results obtained with other models; they permit inferences to the more inclusive and representative of the reference population; and they provide the strongest control for selection bias and specification bias as alternative explanations. Thus, we focus on those results.
DATA
Our analyses were limited to the 11 States with sufficient SELECT enrollment in February 1994. Illinois, Massachusetts, and Washington were excluded from analysis because they did not have SELECT enrollment at that time, and North Dakota was excluded because the sample size available in that State was too small to permit reliable estimation For both the SELECT and comparison groups, we obtained all Medicare claims, Part A and Part B, for services provided during the 4-year interval, 1991 through 1994. The utilization and cost experience was then summarized by beneficiary for each of the 16 quarters in that interval. Thus, our data include a maximum of 16 observations for each beneficiary. Moreover, for each beneficiary, our data include only those quarters for which the beneficiary was alive, continuously eligible for Medicare (both Parts A and B), and not enrolled in an HMO.
The number of beneficiaries enrolled in SELECT ranged from 400-500 in Indiana and Ohio to more than 25,000 in Alabama, California, and Minnesota (Table 2 ). The sample includes only beneficiaries newly enrolled in SELECT products. Rollovers from pre-OBRA network-based medigap products were excluded so that the pre-SELECT period did not represent enrollment in a similar network-based medigap product. In each State we sought to have an approximately equal number of non-SELECT comparison beneficiaries. 4 However, the number of non-SELECT beneficiaries in Alabama, Kentucky, and Minnesota is substantially less than the number of SELECT beneficiaries (Table 2 , third column) because the sampling frame did not include a sufficient number of newly enrolled non-SELECT beneficiaries to match the newly enrolled SELECT universe. Such imbalances reduce the precision in estimating the SELECT effects but do not bias or otherwise invalidate the findings. The average number of quarterly observations per beneficiary ranged from 10.6 to 13.6 for the SELECT sample, and from 12.0 to 13.7 for the comparison group. There are several reasons for having fewer than 16 quarters of data. First, the enrollment in post-OBRA products is weighted toward those newly eligible for Medicare (i.e., those just reaching age 65), and naturally no claims data are available for times prior to first date of Medicare eligibility. Second, for Medicare beneficiaries previously enrolled in an HMO, the Medicare program collects no utilization and cost information for the interval of HMO enrollment. In several States (e.g., Wisconsin and Indiana), a substantial proportion of SELECT enrollees were formerly enrolled in an HMO. Third, a small number of beneficiaries died during the 16-quarter period.
RESULTS

Total Cost Per Beneficiary
Our results show that the effect of SELECT varies widely across States (Table  3 ). Significant, positive (cost-increasing) estimates are obtained for five States- Alabama, Arizona, Indiana, Texas, and Wisconsin; and significant, negative (costdecreasing) estimates are obtained for three States-California, Missouri, and Ohio. The significant, positive effects range from a low of 7.9 percent in Texas to a high of 45.9 percent in Indiana; and the significant, negative effects range from -18.9 percent in Ohio to -8.2 percent in California.
The simple average of all 11 State-specific estimates is +5.6 percent. This estimated average effect is significant at the 0.01 level, and the 95-percent confidence interval ranges from +2.3 percent to +8.9 percent. Excluding Indiana and Ohio, the two States with the smallest sample sizes and most extreme values, the simple average of the remaining estimates is +3.8 percent. This estimate is also significantly greater than zero at the 0.01 level. Its 95-percent confidence interval ranges from +1.5 percent to +6.1 percent.
Weighted averages have not been developed, because we do not believe that it is appropriate to do so. Our State-specific sample sizes do not fairly reflect differences in SELECT market potential across States. The State-to-State differences in SELECT enrollment in our samples are substantially the result of differences in insurer marketing strategy and State insurance department regulatory policy rather than a reflection of the impact of SELECT managed care provisions. Moreover the SELECT implementations varied considerably across States (Lubalin et al., 1994) . Because we view the 11 State implementations as 11 independent tests of the SELECT concept, the simple average is the more relevant summary statistic.
Any summary statistic that averages the results for States, including our simple arithmetic average, should nevertheless be used cautiously because the effects vary so much across States. In particular, a simple average of program effects should not be construed as an estimate of the national effect of the SELECT program. The SELECT States were not constructed as a representative sample of States or Medicare beneficiaries, and we have no way of anticipating how other States would implement SELECT.
Medigap Estimate
We included a medigap program variable to control for supplemental insurance effects other than SELECT. The coefficient of the MEDIGAP variable indicates the effect of enrollment in a post-OBRA traditional supplement (Table 4) . We obtain positive (cost-increasing) estimates for all 11 States, and all but two are significant. The estimates range from +7.4 percent to +29.6 percent, and the average is +19.0 percent. This average is significant at the 0.01 level, and the 95-percent confidence interval ranges from 15.8 percent to 22.7 percent.
Our results for the MEDIGAP variable reconfirm and support findings from other studies that have consistently found supplemental insurance to be associated with increased Medicare utilization and costs. We included the MEDIGAP variable to control for this effect. Clearly, if we had not done so, our estimates of the SELECT effects would have been biased upward substantially. The estimates for the SELECT impacts are incremental or additive to the MEDIGAP impacts.
Full Model Results-An Illustrative Example
For illustrative purposes we report full results for California, for both the fixedeffects and cross-section/time-series models (Table 5 ). Both models indicate that the Medicare costs vary significantly with the QUARTER time-trend variable. Also both indicate that costs are significantly higher in the spring quarter (relative to winter.) The fixed-effects model additionally finds that the costs are significantly lower in the fall.
The cross-section/time-series model finds that women have higher costs. This model also indicates that Medicare costs decline with age until age 65 and then increase monotonically until age 85. We additionally find that costs are significantly lower for persons whose race is neither black nor white. Although we find, as expected, that Medicare costs are sub- stantially higher for the disabled and those with renal disease, we also find that such beneficiaries are relatively less expensive when also entitled by reason of age.
Other Cost and Utilization Measures
The previous discussion focuses on results obtained with our most comprehensive cost measure, which is total allowable Medicare cost. However, we also investigated the effects of SELECT on 13 additional dependent variables measuring less comprehensive cost and utilization outcomes (Tables 6, 7 , and 8). These component results help to validate and explain the more inclusive cost results Table 6 reports the SELECT coefficient estimates for various Part B cost measures; Table 7 reports the estimates for total Medicare costs by setting; and Table   8 reports the estimates for selected utilization measures. These are the actual coefficients estimated from the model, not estimates of the percentage effect.
5 Table 9 provides supplemental information on hospital admissions. We now consider the pattern of results for each study State.
Alabama
Consistent with our estimate of a significant, positive (cost-increasing) effect on total Medicare costs, we obtain significant, cost-increasing estimates on SELECT for all seven component cost measures (primary care physician [PCP], specialty physician, ancillary services, total Part B, physician office, outpatient department, and inpatient hospital) included in Tables 6 and 7 . Moreover, our results indicate that SELECT is associated with both increased ambulatory costs and increased inpatient costs. In Table 8 , which reports the SELECT effect on utilization measures, we find only that SELECT is associated with a greater office visit intensity. The SELECT variable is not significant in any of the three inpatient utilization models. This prompts us to ask, "How can SELECT increase inpatient costs without also increasing inpatient use?" Table 9 suggests an answer.
For the SELECT and non-SELECT hospital admissions in each State, Table 9 shows (1) the average diagnosis-related group (DRG) case-mix weight, (2) the percentage admitted to a teaching hospital, and (3) the percentage in a disproportionate-share hospital. For Alabama we observe no difference in the average case-mix weights, and we find that a somewhat lesser percentage of SELECT patients are admitted to disproportionateshare hospitals. However, we also find that a substantially greater percentage of SELECT patients are admitted to teaching hospitals-43 percent of SELECT patients compared with 33 percent of non-SELECT patients. Inasmuch as Medicare pays teaching hospitals additionally for direct and indirect medical education costs, otherwise similar patients (e.g., ones with the same DRG case weight) admitted to a teaching hospital are more costly.
Arizona
We already reported that SELECT increased Medicare costs in Arizona. The results in Table 6 suggest that specialist and associated ancillary service costs are increased. Although no significant cost effects are seen in Table 7 , significant, utilization-increasing coefficient estimates are obtained for all three ambulatory utilization measures in Table 8 .
In Table 9 we see that Arizona SELECT patients are both less likely to be admitted to a teaching hospital (20 percent compared with 42 percent) and less likely to be admitted to a disproportionateshare hospital (17 percent compared with 46 percent). Thus, SELECT patients are being admitted to less costly hospitals. We also see from Table 9 that the SELECT patients have a somewhat higher case-mix index, 1.63 compared with 1.45. This could suggest that Arizona SELECT plans have enrolled a less favorable risk (i.e., patients requiring more costly, higher intensity care). The fixedeffects procedure controls for such differences in estimating SELECT effects to the extent that the risk-profile differences existed prior to SELECT enrollment.
California
Our results indicate that Medicare is saving money on SELECT in California. The supplemental results in Tables 6 and  7 suggest that the cost savings are coming entirely from ambulatory care. Both physician office and hospital outpatient department (OPD) costs are reduced, and the costs are reduced for PCPs, specialists, and ancillary services. The OPD utilization measure (Table 8) also elicits a significant, negative coefficient. Finally, as seen in Table 9 , the characteristics of SELECT and non-SELECT hospital admissions in California are similar.
Florida
Although a negative coefficient was obtained, SELECT is not estimated to significantly reduce total Medicare costs in Florida. Nevertheless, as in California, it appears that any Florida cost savings are coming from ambulatory care. Our results indicate that physician visit rates are significantly reduced (Table 8 ), and that OPD and ancillary costs are significantly lower (Tables 6 and 7 ). Although we also obtain a negative estimate for the impact on physician office costs, this estimate is not significant. On the other hand, our results indicate that PCP costs are increased. No effect on inpatient costs is shown.
A modestly lower percentage of SELECT patients in Florida are admitted to teaching hospitals and a modestly higher percentage are admitted to disproportionate-share hospitals ( Table 9 ). The average case-mix weights are virtually identical for the two groups.
Indiana
Although the sample size for Indiana is small compared with 9 of the other 10 States, we nevertheless estimate that SELECT has a significant and sizable cost-increasing effect in this State. With the exception of PCP costs, we obtain significant, positive coefficients for all cost measures included in Tables 6 and 7 .
In Indiana 15 percent of the SELECT enrollees had been disenrolled from an HMO, compared with only 1.6 percent of non-SELECT enrollees. If the HMO disenrollees were not only sicker than average but also getting sicker at a disproportionate rate, our estimation would attribute a positive cost impact to SELECT. Comparatively little is known, however, about the health status or health-status progression of HMO disenrollees. In other SELECT States, except Wisconsin, we do not observe similar imbalance in the distribution of HMO disenrollees across SELECT and non-SELECT groups.
In Wisconsin, however, the situation was qualitatively different. A staff-model HMO converted its entire Medicare risk program to SELECT. Thus selection bias should be a less important factor in that State.
Kentucky and Minnesota
In both Kentucky and Minnesota, we detected no significant effects on overall Medicare costs. Those results are generally mirrored by other findings reported in Tables 6, 7, 8, and 9 . In Kentucky we find that, although ancillary costs are increased, utilization is shifted toward more cost-effective settings. The OPD visit rate is reduced, but the office visit rate and the ambulatory surgery rate are increased. SELECT patients in Kentucky are much less likely to use a disproportionate-share hospital-25 percent of SELECT admissions compared with 53 percent of non-SELECT admissions. SELECT patients are also less likely to use a teaching hospital.
For Minnesota none of the cost measures in Tables 6 and 7 elicits a significant coefficient. We find only that inpatient days are significantly increased. Moreover, SELECT patients are somewhat more likely to use disproportionate-share hospitals (Table 9) .
Missouri
SELECT is estimated to reduce overall Medicare costs in Missouri. Our results in Table 6 indicate a consistent pattern of Part B cost reductions associated with SELECT. Tables 7 and 8 , however, suggest that the cost savings are coming largely from the hospital outpatient department. This finding is not surprising, given that all three SELECT insurers in Missouri use hospital-only networks, which would only suggest a potential change in hospital use and cost. No impact on inpatient costs is measured, despite a somewhat greater use of teaching hospitals (54 percent of SELECT admissions compared with 43 percent of non-SELECT admissions).
Ohio
We estimate that overall Medicare costs are reduced for SELECT enrollees in Ohio. Our component cost estimates suggest that the savings are achieved on primary care and ancillary services (Table 6) . Although a negative coefficient was also obtained for physician office costs (Table  7) , the estimate is not quite significant.
We find that inpatient days are significantly reduced, which should imply reduced inpatient costs. However, no significant effect on inpatient costs is indicated (Table 7) . Table 9 shows that the SELECT patients are both somewhat less likely to use teaching hospitals and substantially more likely to use disproportionate-share hospitals. Evidently the inpatient utilization reductions are offset by higher reimbursement rates. Although it should not affect the estimation, we additionally note that the average case-mix weight for SELECT admissions in Ohio is slightly higher than that for non-SELECT admissions.
Texas
As found in the aggregate, the Texas results for component measures provide fairly consistent evidence that SELECT has increased Medicare costs. We obtain significant, positive estimates for all cost measures in Table 7 . Moreover, the utilization results indicate that inpatient admissions and inpatient days are significantly increased. Only the ambulatory surgery rate is significantly lower (Table 8) , perhaps signaling a shift to inpatient surgery. Inpatient costs are significantly higher despite the fact that SELECT patients are substantially less likely to be admitted to a teaching hospital (19 percent of SELECT admissions compared with 30 percent of non-SELECT admissions).
Wisconsin
In Wisconsin SELECT was estimated to increase aggregate Medicare costs. In Tables 6 and 7 , we find evidence for costincreasing effects only in the physician office setting. No effects on OPD or inpatient costs are indicated. Moreover PCP and specialty physician costs are both increased, as are total Part B costs. However, we do not find in Table 8 that the office visit rate is significantly increased. Wisconsin's SELECT patients are less likely to use teaching hospitals, but there is no difference in the use of disproportionate-share hospitals or the average case-mix weights.
On balance we believe that these supplemental analyses, using other cost and utilization measures, give results that are broadly consistent with our overall cost findings and significantly validate those results. We also suggest, based on the supplemental analyses, that the cost factors are different in different States. There seems not to be any simple explanation for either increased or reduced costs under SELECT. Like SELECT itself, the dynamic seems to vary by State.
DISCUSSION
Our analysis gives undeniably mixed results, with the estimated effects varying substantially by State. Five States show cost increases; three States show cost decreases; and three States show no effect. Moreover we see no obvious patterns in the SELECT implementations that would explain the variation in findings across States. California, Minnesota, and Wisconsin are all reasonably mature managed care States. One of these States (California) shows a cost decrease, one State (Wisconsin) shows a cost increase, and one State (Minnesota) shows no effect. All SELECT insurers in Indiana, Kentucky, Missouri, Ohio, and Texas use hospital-only provider networks. Two of these States (Indiana and Texas) show cost increases; two (Missouri and Ohio) show cost decreases; and one (Kentucky) shows no effect. SELECT products were based on pre-OBRA network products in Alabama, California, Minnesota, and Wisconsin. Two of these States (Alabama and Wisconsin) show cost increases, one (California) shows a cost decrease, and one (Minnesota) shows no effect.
Although significant inpatient effects were indicated in three States (Alabama, Indiana, and Texas), we find that the cost effects more consistently reflect differences in ambulatory care costs. The estimated effects on physician office costs are significant in 5 of the 11 study States; and the estimated effects on OPD costs are significant in 6 States.
In general, we believe that our fixedeffects results reflect actual SELECT program effects and cannot be easily attributed to either selection or specification biases. We do not, however, preclude the prospect that biases of one kind or another have skewed our estimates in one or more States. In particular we are concerned that we did not know the medigap insurance status of beneficiaries prior to purchase of their current policy. We are also concerned that the estimates for Indiana do not reflect true SELECT program effects because the effect is so large and the rate of transfer from Medicare HMOs is so much higher among SELECT beneficiaries than among comparison group members. On the other hand, we think it unlikely that analytic biases could explain the overall pattern of results. Indeed the mixed nature of our findings tends to make the estimates all the more credible, because it is difficult to posit any other explanation.
The original premise of SELECT had been that it would reduce aggregate health care costs because SELECT insurers would have an incentive to establish cost-effective provider networks and then support the networks in improving health system efficiency. The case study found that, as implemented by most insurers, SELECT is a comparatively weak form of managed care (Lubalin et al., 1994) . Many SELECT insurers do not include physicians in their provider networks, choosing instead to recruit hospitals that discount or waive the Part A deductible and to cover the Part B deductible and coinsurance for any physician that the beneficiary decides to use. Most insurers that use physician networks organize them as preferred provider networks without gatekeepers, again, a relatively weak form of managed care. Thus, on the basis of the case study, we had anticipated finding little, if any, effect of SELECT on utilization or costs.
How then does one account for the finding that the SELECT plans in several States have apparently increased health care costs? What are the potential mechanisms for affecting such cost increases? We offer three potential explanations.
Like some PPOs, some SELECT plans may have contracted with providers on a discounted-fee basis and not given sufficient attention to managing the overall efficiency of health care services. In some PPOs the providers simply recouped their discounts by providing or billing more services. In other instances the PPOs had, in contracting on a percentage discount basis, unwittingly selected the more costly providers (i.e., the ones with greater margins and thus greater flexibility to accept a discount). Whatever the mechanism, employers found that the PPOs were actually costing them more, much as we are finding with regard to the SELECT experience in several States.
The possibility that SELECT insurers unwittingly chose more expensive providers may explain why SELECT influenced physician costs in Indiana, Missouri, Ohio, and Texas, even though none of the SELECT networks in those States include physicians. The physicians associated with the SELECT network hospitals may be systematically more or less expensive than other physicians used by the comparison population. We encountered no evidence that the ambulatory utilization patterns of physicians affiliated with network hospitals were considered by insurers when they developed hospital-only networks. However, such differences could explain the impact of hospital-only SELECT plans on physician costs, if SELECT beneficiaries were more likely to use physicians affiliated with hospitals in their SELECT network. If this pattern occurred by chance rather than by design, we would expect to see a cost-increasing impact in some cases (e.g., Indiana and Texas) and a cost-decreasing impact in others (e.g., Missouri and Ohio), as we have found.
Finally, in Wisconsin, a predominantly rural State, the increased costs might arise as a result of SELECT's role in improving health care access. In many rural and other underserved areas, Medicare risk-contracting HMOs have found that they are unwilling or unable to provide Medicare services within the adjusted average per capita cost experience-based capitation. They argue that access barriers have impeded health care use by the FFS population and left traditional Medicare beneficiaries with untreated or inadequately treated problems. They further argue that beneficiaries who join a multispecialty HMO receive more intensive and expensive treatment than they otherwise would have received from community providers under FFS Medicare. Consequently, the costs of care provided to SELECT benefi-
